Dopamine agonists for pituitary tumours: to treat or not?

31 May 2017


The benefits and risks of giving patients medical therapy after surgery to prevent regrowth of nonfunctioning pituitary adenomas was debated at the European Congress of Endocrinology 2017, with the final vote revealing a 50-50 split of opinion from the audience.

Medscape


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story